25 XP   0   0   10

Alterity Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse Alterity Therapeutics Ltd together

PenkeI guess you are interested in Alterity Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alterity Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alterity Therapeutics Ltd

I send you an email if I find something interesting about Alterity Therapeutics Ltd.

Quick analysis of Alterity Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Alterity Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-53.4%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.005 - A$0.007
How sure are you?
50%

1. Valuation of Alterity Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.03 - A$0.00

Total Value Per Share

A$-0.03 - A$0.00

2. Growth of Alterity Therapeutics Ltd (5 min.)




Is Alterity Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$11.5m$20.8m-$7m-50.5%

How much money is Alterity Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$3.5m$200k6.0%
Net Profit Margin-365.7%-225.0%--

How much money comes from the company's main activities?

3. Financial Health of Alterity Therapeutics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#614 / 1007

Most Revenue
#458 / 1007

Most Profit
#555 / 1007

Most Efficient
#737 / 1007

What can you expect buying and holding a share of Alterity Therapeutics Ltd? (5 min.)

Welcome investor! Alterity Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Alterity Therapeutics Ltd.

What can you expect buying and holding a share of Alterity Therapeutics Ltd?

First you should know what it really means to hold a share of Alterity Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Alterity Therapeutics Ltd is A$0.005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alterity Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alterity Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alterity Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-16.3%0.00-12.7%0.00-11.5%0.00-10.5%0.00-9.0%
Usd Book Value Change Per Share0.00-13.0%0.00-8.8%0.00-8.2%0.000.9%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-13.0%0.00-8.8%0.00-8.2%0.000.9%0.00-0.1%
Usd Price Per Share0.00-0.00-0.01-0.01-0.06-
Price to Earnings Ratio-1.41--2.06--4.92--7.89--52.63-
Price-to-Total Gains Ratio-7.07--104.32--378.03--531.68--113,799.88-
Price to Book Ratio2.08-1.76-2.29-6.64-15.88-
Price-to-Total Gains Ratio-7.07--104.32--378.03--531.68--113,799.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.003285
Number of shares304414
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (304414 shares)-133.3913.46
Gains per Year (304414 shares)-533.5753.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-534-54405444
20-1067-1078010898
30-1601-16120162152
40-2134-21460215206
50-2668-26800269260
60-3201-32140323314
70-3735-37480377368
80-4269-42820431422
90-4802-48160485476
100-5336-53500539530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%0.045.00.00.0%
Book Value Change Per Share0.03.00.00.0%1.07.03.09.1%4.011.04.021.1%6.028.05.015.4%9.030.06.020.0%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.045.00.0%
Total Gains per Share0.03.00.00.0%1.07.03.09.1%4.011.04.021.1%6.028.05.015.4%9.030.06.020.0%

Fundamentals of Alterity Therapeutics Ltd

About Alterity Therapeutics Ltd

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-05-04 15:55:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alterity Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alterity Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -342.4% means that $-3.42 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is -342.4%. The company is making a huge loss. -2
  • The TTM is -365.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-342.4%TTM-365.7%+23.3%
TTM-365.7%YOY-225.0%-140.7%
TTM-365.7%5Y-175.0%-190.7%
5Y-175.0%10Y-180.6%+5.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-342.4%-207.2%-135.2%
TTM-365.7%-216.8%-148.9%
YOY-225.0%-282.4%+57.4%
5Y-175.0%-426.4%+251.4%
10Y-180.6%-589.3%+408.7%
1.1.2. Return on Assets

Shows how efficient Alterity Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -29.3% Return on Assets means that Alterity Therapeutics Ltd generated $-0.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alterity Therapeutics Ltd:

  • The MRQ is -29.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.3%TTM-20.3%-9.0%
TTM-20.3%YOY-14.7%-5.6%
TTM-20.3%5Y-22.9%+2.6%
5Y-22.9%10Y-17.1%-5.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.3%-13.0%-16.3%
TTM-20.3%-12.5%-7.8%
YOY-14.7%-11.2%-3.5%
5Y-22.9%-13.6%-9.3%
10Y-17.1%-15.2%-1.9%
1.1.3. Return on Equity

Shows how efficient Alterity Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -36.9% Return on Equity means Alterity Therapeutics Ltd generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alterity Therapeutics Ltd:

  • The MRQ is -36.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.9%TTM-25.9%-11.1%
TTM-25.9%YOY-17.9%-8.0%
TTM-25.9%5Y-29.0%+3.1%
5Y-29.0%10Y-21.6%-7.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.9%-16.6%-20.3%
TTM-25.9%-15.7%-10.2%
YOY-17.9%-14.2%-3.7%
5Y-29.0%-18.9%-10.1%
10Y-21.6%-19.9%-1.7%

1.2. Operating Efficiency of Alterity Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alterity Therapeutics Ltd is operating .

  • Measures how much profit Alterity Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -448.2% means the company generated $-4.48  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is -448.2%. The company is operating very inefficient. -2
  • The TTM is -454.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-448.2%TTM-454.7%+6.5%
TTM-454.7%YOY-295.2%-159.6%
TTM-454.7%5Y-241.0%-213.7%
5Y-241.0%10Y-217.4%-23.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-448.2%-285.4%-162.8%
TTM-454.7%-226.2%-228.5%
YOY-295.2%-288.4%-6.8%
5Y-241.0%-469.6%+228.6%
10Y-217.4%-599.3%+381.9%
1.2.2. Operating Ratio

Measures how efficient Alterity Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.48 means that the operating costs are $4.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 4.482. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.779. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.482TTM4.779-0.297
TTM4.779YOY3.155+1.624
TTM4.7795Y2.650+2.129
5Y2.65010Y2.764-0.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4823.231+1.251
TTM4.7793.303+1.476
YOY3.1553.763-0.608
5Y2.6505.586-2.936
10Y2.7647.464-4.700

1.3. Liquidity of Alterity Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.90 means the company has $4.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 4.895. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.747. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.895TTM5.747-0.852
TTM5.747YOY6.708-0.961
TTM5.7475Y7.561-1.814
5Y7.56110Y9.766-2.206
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8953.855+1.040
TTM5.7474.160+1.587
YOY6.7085.323+1.385
5Y7.5616.122+1.439
10Y9.7666.480+3.286
1.3.2. Quick Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 4.07 means the company can pay off $4.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 4.074. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.076. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.074TTM5.076-1.002
TTM5.076YOY6.494-1.418
TTM5.0765Y6.174-1.098
5Y6.17410Y8.618-2.444
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0743.506+0.568
TTM5.0764.001+1.075
YOY6.4945.390+1.104
5Y6.1746.127+0.047
10Y8.6186.488+2.130

1.4. Solvency of Alterity Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alterity Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alterity Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21 means that Alterity Therapeutics Ltd assets are financed with 20.6% credit (debt) and the remaining percentage (100% - 20.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.206. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.177. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.206TTM0.177+0.029
TTM0.177YOY0.150+0.027
TTM0.1775Y0.159+0.018
5Y0.15910Y0.128+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2060.344-0.138
TTM0.1770.339-0.162
YOY0.1500.275-0.125
5Y0.1590.368-0.209
10Y0.1280.389-0.261
1.4.2. Debt to Equity Ratio

Measures if Alterity Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 25.9% means that company has $0.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.259. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.230. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.259TTM0.230+0.030
TTM0.230YOY0.184+0.046
TTM0.2305Y0.204+0.026
5Y0.20410Y0.166+0.038
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2590.390-0.131
TTM0.2300.408-0.178
YOY0.1840.341-0.157
5Y0.2040.438-0.234
10Y0.1660.469-0.303

2. Market Valuation of Alterity Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alterity Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.41 means the investor is paying $-1.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -1.006. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.409. Based on the earnings, the company is expensive. -2
  • The TTM is -2.057. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.006MRQ-1.409+0.402
MRQ-1.409TTM-2.057+0.648
TTM-2.057YOY-4.917+2.860
TTM-2.0575Y-7.889+5.832
5Y-7.88910Y-52.626+44.737
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.006-2.351+1.345
MRQ-1.409-2.599+1.190
TTM-2.057-2.762+0.705
YOY-4.917-4.025-0.892
5Y-7.889-6.305-1.584
10Y-52.626-6.538-46.088
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -1.346. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.884. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.014. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.346MRQ-1.884+0.538
MRQ-1.884TTM-2.014+0.130
TTM-2.014YOY-32.841+30.827
TTM-2.0145Y-735,171.703+735,169.689
5Y-735,171.70310Y-359,343.263-375,828.440
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.346-3.010+1.664
MRQ-1.884-3.306+1.422
TTM-2.014-3.607+1.593
YOY-32.841-5.524-27.317
5Y-735,171.703-8.299-735,163.404
10Y-359,343.263-8.910-359,334.353
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alterity Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.08 means the investor is paying $2.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is 1.486. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.081. Based on the equity, the company is underpriced. +1
  • The TTM is 1.762. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.486MRQ2.081-0.594
MRQ2.081TTM1.762+0.318
TTM1.762YOY2.289-0.527
TTM1.7625Y6.643-4.881
5Y6.64310Y15.881-9.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4862.019-0.533
MRQ2.0812.116-0.035
TTM1.7622.099-0.337
YOY2.2892.873-0.584
5Y6.6433.556+3.087
10Y15.8813.946+11.935
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alterity Therapeutics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Alterity Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001-33%-0.001-37%0.000-1572%0.000-99%
Book Value Per Share--0.0030.004-17%0.006-45%0.005-27%0.005-32%
Current Ratio--4.8955.747-15%6.708-27%7.561-35%9.766-50%
Debt To Asset Ratio--0.2060.177+16%0.150+37%0.159+29%0.128+61%
Debt To Equity Ratio--0.2590.230+13%0.184+41%0.204+27%0.166+56%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.001-22%-0.001-30%-0.001-36%-0.001-45%
Free Cash Flow Per Share---0.001-0.001-5%-0.001-45%-0.001-6%-0.001-27%
Free Cash Flow To Equity Per Share---0.001-0.001+9%-0.001-32%0.000-89%0.000-45%
Gross Profit Margin--1.0031.002+0%1.003+0%1.003+0%1.012-1%
Intrinsic Value_10Y_max---0.003--------
Intrinsic Value_10Y_min---0.029--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.006--------
Intrinsic Value_3Y_min---0.010--------
Intrinsic Value_5Y_max---0.007--------
Intrinsic Value_5Y_min---0.016--------
Market Cap26190100.480-40%36666140.67236666140.6720%73332281.344-50%116890553.721-69%454096049.861-92%
Net Profit Margin---3.424-3.657+7%-2.250-34%-1.750-49%-1.806-47%
Operating Margin---4.482-4.547+1%-2.952-34%-2.410-46%-2.174-51%
Operating Ratio--4.4824.779-6%3.155+42%2.650+69%2.764+62%
Pb Ratio1.486-40%2.0811.762+18%2.289-9%6.643-69%15.881-87%
Pe Ratio-1.006+29%-1.409-2.057+46%-4.917+249%-7.889+460%-52.626+3636%
Price Per Share0.005-40%0.0070.0070%0.014-50%0.022-69%0.087-92%
Price To Free Cash Flow Ratio-1.346+29%-1.884-2.014+7%-32.841+1643%-735171.703+39018027%-359343.263+19071501%
Price To Total Gains Ratio-5.046+29%-7.065-104.321+1377%-378.031+5251%-531.682+7425%-113799.883+1610635%
Quick Ratio--4.0745.076-20%6.494-37%6.174-34%8.618-53%
Return On Assets---0.293-0.203-31%-0.147-50%-0.229-22%-0.171-42%
Return On Equity---0.369-0.259-30%-0.179-52%-0.290-22%-0.216-41%
Total Gains Per Share---0.001-0.001-33%-0.001-37%0.000-1572%0.000-99%
Usd Book Value--11578407.57913878396.825-17%20891289.942-45%15763899.386-27%17089939.896-32%
Usd Book Value Change Per Share---0.0010.000-33%0.000-37%0.000-1572%0.000-99%
Usd Book Value Per Share--0.0020.003-17%0.004-45%0.003-27%0.003-32%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001-22%-0.001-30%-0.001-36%0.000-45%
Usd Free Cash Flow---3196305.000-3028950.675-5%-1744285.561-45%-2858740.509-11%-2287642.784-28%
Usd Free Cash Flow Per Share---0.001-0.001-5%0.000-45%-0.001-6%0.000-27%
Usd Free Cash Flow To Equity Per Share--0.000-0.001+9%0.000-32%0.000-89%0.000-45%
Usd Market Cap17206896.015-40%24089654.42224089654.4220%48179308.843-50%76797093.795-69%298341104.759-92%
Usd Price Per Share0.003-40%0.0050.0050%0.009-50%0.015-69%0.057-92%
Usd Profit---4275219.231-3322021.950-22%-3522038.702-18%-3462499.996-19%-2701759.941-37%
Usd Revenue--1248775.668919025.616+36%1041852.040+20%727033.503+72%1027800.221+21%
Usd Total Gains Per Share---0.0010.000-33%0.000-37%0.000-1572%0.000-99%
 EOD+3 -5MRQTTM+8 -23YOY+5 -295Y+5 -2910Y+4 -30

4.2. Fundamental Score

Let's check the fundamental score of Alterity Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.006
Price to Book Ratio (EOD)Between0-11.486
Net Profit Margin (MRQ)Greater than0-3.424
Operating Margin (MRQ)Greater than0-4.482
Quick Ratio (MRQ)Greater than14.074
Current Ratio (MRQ)Greater than14.895
Debt to Asset Ratio (MRQ)Less than10.206
Debt to Equity Ratio (MRQ)Less than10.259
Return on Equity (MRQ)Greater than0.15-0.369
Return on Assets (MRQ)Greater than0.05-0.293
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Alterity Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.097
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.005
Ma 100Greater thanMa 2000.005
OpenGreater thanClose0.006
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets22,193
Total Liabilities4,569
Total Stockholder Equity17,623
 As reported
Total Liabilities 4,569
Total Stockholder Equity+ 17,623
Total Assets = 22,193

Assets

Total Assets22,193
Total Current Assets21,993
Long-term Assets199
Total Current Assets
Cash And Cash Equivalents 12,320
Net Receivables 5,984
Other Current Assets 3,688
Total Current Assets  (as reported)21,993
Total Current Assets  (calculated)21,993
+/-0
Long-term Assets
Property Plant Equipment 199
Long-term Assets  (as reported)199
Long-term Assets  (calculated)199
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,493
Long-term Liabilities77
Total Stockholder Equity17,623
Total Current Liabilities
Accounts payable 3,631
Other Current Liabilities 861
Total Current Liabilities  (as reported)4,493
Total Current Liabilities  (calculated)4,493
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)77
Long-term Liabilities  (calculated)0
+/- 77
Total Stockholder Equity
Common Stock214,976
Retained Earnings -201,631
Accumulated Other Comprehensive Income 4,278
Total Stockholder Equity (as reported)17,623
Total Stockholder Equity (calculated)17,623
+/-0
Other
Cash and Short Term Investments 12,320
Common Stock Shares Outstanding 2,503,279
Liabilities and Stockholders Equity 22,193
Net Debt -12,244
Short Long Term Debt Total 77



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-30
> Total Assets 
0
14,888
0
16,341
0
18,256
0
41,164
0
38,858
0
22,199
0
16,243
0
10,427
0
11,986
0
7,721
0
9,827
0
11,723
8,305
4,597
8,613
6,801
3,654
9,011
7,589
7,342
12,812
12,812
17,074
17,074
24,523
24,523
41,641
41,641
39,805
39,805
41,834
41,834
38,593
38,593
33,725
33,725
30,411
30,411
25,281
25,281
21,931
21,931
18,726
18,726
14,146
14,146
19,910
19,910
14,486
14,486
9,908
13,305
0
37,407
0
33,586
44,931
44,931
41,363
41,363
33,383
33,383
27,318
27,318
22,193
22,19327,31827,31833,38333,38341,36341,36344,93144,93133,586037,407013,3059,90814,48614,48619,91019,91014,14614,14618,72618,72621,93121,93125,28125,28130,41130,41133,72533,72538,59338,59341,83441,83439,80539,80541,64141,64124,52324,52317,07417,07412,81212,8127,3427,5899,0113,6546,8018,6134,5978,30511,72309,82707,721011,986010,427016,243022,199038,858041,164018,256016,341014,8880
   > Total Current Assets 
0
1,558
0
3,649
0
6,114
0
29,565
0
27,718
0
22,033
0
16,103
0
10,325
0
11,911
0
7,673
0
9,766
0
11,619
8,182
4,491
8,503
6,708
3,563
8,932
7,519
7,256
12,728
12,728
16,983
16,983
24,432
24,432
41,549
41,549
39,705
39,705
41,744
41,744
38,514
38,514
33,657
33,657
30,331
30,331
25,250
25,250
21,906
21,906
18,655
18,655
14,086
14,086
19,861
19,861
14,368
14,368
9,836
13,233
37,368
37,368
33,489
33,489
44,863
44,863
41,144
41,144
33,208
33,208
27,049
27,049
21,993
21,99327,04927,04933,20833,20841,14441,14444,86344,86333,48933,48937,36837,36813,2339,83614,36814,36819,86119,86114,08614,08618,65518,65521,90621,90625,25025,25030,33130,33133,65733,65738,51438,51441,74441,74439,70539,70541,54941,54924,43224,43216,98316,98312,72812,7287,2567,5198,9323,5636,7088,5034,4918,18211,61909,76607,673011,911010,325016,103022,033027,718029,56506,11403,64901,5580
       Cash And Cash Equivalents 
0
1,446
0
3,454
0
5,619
0
29,401
0
26,930
0
21,366
0
15,713
0
10,020
0
11,545
0
7,408
0
9,170
0
11,243
7,852
4,305
8,372
5,227
2,882
8,838
6,747
5,636
8,842
8,842
13,347
13,347
19,300
19,300
34,167
34,167
29,053
29,053
34,910
34,910
29,059
29,059
28,594
28,594
28,342
28,342
21,885
21,885
19,911
19,911
15,236
15,236
8,383
8,383
14,400
14,400
12,179
12,179
9,197
9,197
0
35,042
0
28,116
37,002
37,002
34,807
34,807
25,338
25,338
15,774
15,774
12,320
12,32015,77415,77425,33825,33834,80734,80737,00237,00228,116035,04209,1979,19712,17912,17914,40014,4008,3838,38315,23615,23619,91119,91121,88521,88528,34228,34228,59428,59429,05929,05934,91034,91029,05329,05334,16734,16719,30019,30013,34713,3478,8428,8425,6366,7478,8382,8825,2278,3724,3057,85211,24309,17007,408011,545010,020015,713021,366026,930029,40105,61903,45401,4460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42
0
0
0
46
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153
0
0
0
0
0
0
0
44
157
157
0
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000100157157440000000153000000000000000000000004600042000000000000000
       Net Receivables 
0
61
0
143
0
455
0
92
0
519
0
174
0
232
0
194
0
150
0
70
0
211
0
121
71
1
11
1
1
3
692
1,552
0
3,785
0
3,526
0
4,982
0
7,320
0
10,430
0
6,522
0
9,249
0
4,754
0
1,847
0
3,036
0
1,448
3,152
3,152
5,590
5,590
4,829
4,829
1,880
1,880
61
3,458
1,977
1,977
4,278
4,278
6,261
6,261
4,725
4,725
7,077
7,077
8,666
8,666
5,984
5,9848,6668,6667,0777,0774,7254,7256,2616,2614,2784,2781,9771,9773,458611,8801,8804,8294,8295,5905,5903,1523,1521,44803,03601,84704,75409,24906,522010,43007,32004,98203,52603,78501,55269231111171121021107001500194023201740519092045501430610
       Other Current Assets 
0
50
0
52
0
40
0
1
0
268
0
493
0
158
0
0
0
216
0
26
0
385
0
11
259
185
120
1,480
681
91
80
67
0
101
0
110
0
150
0
63
0
222
0
153
0
206
0
310
0
143
0
44
0
390
10
0
113
113
10
10
310
310
10
10
349
349
9
9
1,600
1,600
10
10
793
793
40
40
3,688
3,688404079379310101,6001,60099349349101031031010101131130103900440143031002060153022206301500110010106780916811,480120185259110385026021600015804930268010400520500
   > Long-term Assets 
0
13,330
0
12,692
0
12,142
0
11,598
0
11,140
0
166
0
140
0
102
0
75
0
48
0
61
0
105
123
106
110
94
91
79
70
86
84
84
91
91
48
92
48
92
100
100
45
90
33
79
24
68
36
80
31
31
25
25
71
71
60
60
49
49
117
117
71
71
0
38
0
97
68
68
219
219
175
175
269
269
199
1992692691751752192196868970380717111711749496060717125253131803668247933904510010092489248919184848670799194110106123105061048075010201400166011,140011,598012,142012,692013,3300
       Property Plant Equipment 
0
189
0
141
0
106
0
180
0
194
0
166
0
140
0
102
0
75
0
48
0
61
0
69
88
71
75
59
56
41
33
48
46
46
47
47
48
48
48
48
56
56
45
45
33
33
24
24
36
36
31
31
25
25
71
71
60
60
49
49
117
117
71
71
38
38
97
97
68
68
219
219
175
175
269
269
199
199269269175175219219686897973838717111711749496060717125253131363624243333454556564848484847474646483341565975718869061048075010201400166019401800106014101890
       Intangible Assets 
0
13,142
0
12,551
0
12,036
0
11,419
0
10,946
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000010,946011,419012,036012,551013,1420
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
0
44
0
0
0
45
0
45
0
44
44
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000044444404504500044044000000000000000000000000000000000000
> Total Liabilities 
0
1,151
0
565
0
1,687
0
2,696
0
1,475
0
2,684
0
1,192
0
1,693
0
3,814
0
2,110
0
4,230
0
1,836
2,132
847
963
1,572
1,105
2,080
2,072
1,718
3,346
3,346
3,099
3,099
4,731
4,732
3,952
3,955
3,291
3,298
2,719
2,721
2,350
2,351
2,357
2,357
2,850
2,850
1,590
1,591
1,815
1,816
2,644
2,645
3,221
3,223
3,320
3,355
3,240
3,288
2,715
2,757
0
3,050
0
3,115
3,802
3,802
5,894
5,894
5,232
5,279
4,382
4,505
4,569
4,5694,5054,3825,2795,2325,8945,8943,8023,8023,11503,05002,7572,7153,2883,2403,3553,3203,2233,2212,6452,6441,8161,8151,5911,5902,8502,8502,3572,3572,3512,3502,7212,7193,2983,2913,9553,9524,7324,7313,0993,0993,3463,3461,7182,0722,0801,1051,5729638472,1321,83604,23002,11003,81401,69301,19202,68401,47502,69601,687056501,1510
   > Total Current Liabilities 
0
1,151
0
563
0
1,680
0
2,688
0
1,460
0
2,639
0
1,127
0
1,616
0
1,162
0
1,739
0
1,983
0
972
2,030
799
897
1,500
1,101
2,075
2,065
1,711
3,346
3,346
3,099
3,099
4,731
4,731
3,952
3,952
3,291
3,291
2,719
2,719
2,350
2,350
2,357
2,357
2,850
2,850
1,590
1,590
1,815
1,815
2,644
2,644
3,221
3,221
3,320
3,320
3,240
3,240
2,715
2,715
3,042
3,042
3,068
3,068
3,762
3,762
5,820
5,820
5,232
5,232
4,382
4,382
4,493
4,4934,3824,3825,2325,2325,8205,8203,7623,7623,0683,0683,0423,0422,7152,7153,2403,2403,3203,3203,2213,2212,6442,6441,8151,8151,5901,5902,8502,8502,3572,3572,3502,3502,7192,7193,2913,2913,9523,9524,7314,7313,0993,0993,3463,3461,7112,0652,0751,1011,5008977992,03097201,98301,73901,16201,61601,12702,63901,46002,68801,680056301,1510
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42
0
0
0
46
0
0
0
0
0
0
0
0
0
290
0
299
0
436
0
803
0
840
0
0
0
0
0
153
0
0
0
0
0
0
0
44
0
157
0
10
0
0
0
0
0
0
0
33
0
0
0
28
15
15
58
58
0
0
0
107
0
0107000585815152800033000000010015704400000001530000084008030436029902900000000004600042000000000000000
       Accounts payable 
0
1,151
0
540
0
1,631
0
2,646
0
1,398
0
2,561
0
1,071
0
953
0
1,035
0
460
0
1,898
0
851
1,657
604
682
1,244
789
311
1,384
202
2,122
2,122
279
279
3,051
3,051
651
651
2,640
2,640
362
362
1,770
1,770
312
312
2,120
2,120
65
65
1,230
1,230
1,334
1,334
2,671
2,671
1,694
1,694
2,624
2,624
954
954
2,325
2,325
1,449
1,449
3,134
3,134
2,689
2,689
4,445
4,445
1,716
1,716
3,631
3,6311,7161,7164,4454,4452,6892,6893,1343,1341,4491,4492,3252,3259549542,6242,6241,6941,6942,6712,6711,3341,3341,2301,23065652,1202,1203123121,7701,7703623622,6402,6406516513,0513,0512792792,1222,1222021,3843117891,2446826041,65785101,898046001,035095301,07102,56101,39802,64601,631054001,1510
       Other Current Liabilities 
0
0
0
24
0
49
0
42
0
62
0
78
0
56
0
663
0
127
0
1,279
0
86
0
121
373
195
215
256
311
2,075
681
88
1,224
755
2,820
1,984
1,680
800
3,300
3,300
651
651
2,356
2,356
580
580
2,046
2,046
730
730
1,525
1,525
585
585
1,310
1,310
550
550
1,626
1,626
616
616
1,760
1,728
9
717
34
1,591
613
628
3,074
-27
787
787
2,666
2,666
861
8612,6662,666787787-273,0746286131,5913471791,7281,7606166161,6261,6265505501,3101,3105855851,5251,5257307302,0462,0465805802,3562,3566516513,3003,3008001,6801,9842,8207551,224886812,07531125621519537312108601,27901270663056078062042049024000
   > Long-term Liabilities 
0
0
0
1
0
7
0
8
0
15
0
45
0
65
0
77
0
2,651
0
371
0
2,246
0
864
103
48
65
72
4
4
6
7
0
0
0
0
0
1
0
3
0
6
0
2
0
1
0
0
0
0
0
0
0
1
0
1
0
1
0
35
0
48
0
42
0
8
0
48
40
40
74
74
0
47
0
123
77
771230470747440404808042048035010101000000010206030100000764472654810386402,246037102,651077065045015080701000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
38
0
27
0
60
0
29
0
103
0
01030290600270380001000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
35
35
48
48
42
42
8
8
10
10
13
13
14
14
18
18
20
20
0
020201818141413131010884242484835351111000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
13,737
0
15,777
0
16,570
0
38,467
0
37,383
0
19,515
0
15,051
0
8,735
0
8,173
0
5,611
0
5,598
0
9,888
6,173
3,750
7,650
5,229
2,549
6,931
5,517
5,623
-3,535
9,465
746
13,975
7,534
19,791
26,047
37,686
24,723
36,507
27,048
39,113
24,177
36,242
19,302
31,367
15,496
27,561
21,370
23,690
17,633
20,116
14,327
16,081
9,710
10,923
15,396
16,555
10,039
11,198
6,285
10,548
0
34,356
0
30,470
41,129
41,129
35,469
35,469
24,444
28,104
18,840
22,813
17,623
17,62322,81318,84028,10424,44435,46935,46941,12941,12930,470034,356010,5486,28511,19810,03916,55515,39610,9239,71016,08114,32720,11617,63323,69021,37027,56115,49631,36719,30236,24224,17739,11327,04836,50724,72337,68626,04719,7917,53413,9757469,465-3,5355,6235,5176,9312,5495,2297,6503,7506,1739,88805,59805,61108,17308,735015,051019,515037,383038,467016,570015,777013,7370
   Common Stock
0
13,207
0
16,691
0
21,524
0
49,205
0
55,339
0
55,181
0
55,054
0
55,131
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86,134
90,941
93,643
98,677
101,379
113,394
116,095
137,308
140,009
137,236
139,938
144,194
146,896
144,178
146,879
144,178
144,178
144,023
146,725
144,018
144,018
143,899
143,899
143,910
143,910
144,013
144,013
156,633
156,633
156,922
156,922
160,704
160,704
194,893
194,893
197,448
197,448
213,815
213,815
213,787
213,787
213,827
213,827
213,971
213,971
214,976
214,976213,971213,971213,827213,827213,787213,787213,815213,815197,448197,448194,893194,893160,704160,704156,922156,922156,633156,633144,013144,013143,910143,910143,899143,899144,018144,018146,725144,023144,178144,178146,879144,178146,896144,194139,938137,236140,009137,308116,095113,394101,37998,67793,64390,94186,13400000000000000055,131055,054055,181055,339049,205021,524016,691013,2070
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-145
0
-230
0
14,659
0
14,573
0
14,672
0
14,602
0
2,684
0
-49,266
0
-49,197
0
-52,472
0
6,009
0
6,081
0
-526
0
-330
0
9,495
0
9,633
0
10,299
0
10,527
0
9,556
0
8,937
0
9,082
0
9,363
0
9,363
0
12,065
0
9,363
0
2,320
0
2,483
0
1,754
0
1,213
0
1,159
0
1,159
0
866
0
2,444
0
2,751
3,626
3,626
3,566
3,566
0
3,660
0
3,972
4,278
4,2783,97203,66003,5663,5663,6263,6262,75102,444086601,15901,15901,21301,75402,48302,32009,363012,06509,36309,36309,08208,93709,556010,527010,29909,63309,4950-3300-52606,08106,0090-52,4720-49,1970-49,26602,684014,602014,672014,573014,6590-2300-1450
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
14,811
0
14,848
0
0
0
0
0
0
0
0
0
0
0
0
0
53,852
0
53,977
0
62,175
0
69,992
76,859
77,842
83,433
84,032
84,855
82,341
93,791
0
3,535
0
-746
0
-7,534
0
-26,047
0
-24,723
0
-27,048
0
-24,177
0
-19,302
0
-15,496
0
-21,370
0
-17,633
0
-14,327
1,754
-9,710
1,213
-15,396
1,159
-10,039
1,159
-6,285
866
2,444
2,444
2,751
2,751
3,626
-37,503
3,566
3,566
-24,444
-24,444
-18,840
-18,840
0
0-18,840-18,840-24,444-24,4443,5663,566-37,5033,6262,7512,7512,4442,444866-6,2851,159-10,0391,159-15,3961,213-9,7101,754-14,3270-17,6330-21,3700-15,4960-19,3020-24,1770-27,0480-24,7230-26,0470-7,5340-74603,535093,79182,34184,85584,03283,43377,84276,85969,992062,175053,977053,852000000000000014,848014,8110



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue3,916
Cost of Revenue-285
Gross Profit3,6313,631
 
Operating Income (+$)
Gross Profit3,631
Operating Expense-17,350
Operating Income-14,636-13,718
 
Operating Expense (+$)
Research Development13,199
Selling General Administrative4,988
Selling And Marketing Expenses51
Operating Expense17,35018,238
 
Net Interest Income (+$)
Interest Income16
Interest Expense--
Other Finance Cost-0
Net Interest Income16
 
Pretax Income (+$)
Operating Income-14,636
Net Interest Income16
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-13,702-15,570
EBIT - interestExpense = -14,636
-13,702
-13,807
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-14,636-13,702
Earnings Before Interest and Taxes (EBITDA)-14,598
 
After tax Income (+$)
Income Before Tax-13,702
Tax Provision-104
Net Income From Continuing Ops-13,807-13,807
Net Income-13,807
Net Income Applicable To Common Shares-13,807
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses17,635
Total Other Income/Expenses Net934-16
 

Technical Analysis of Alterity Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alterity Therapeutics Ltd. The general trend of Alterity Therapeutics Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alterity Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alterity Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.007 < 0.007 < 0.007.

The bearish price targets are: 0.005 > 0.005 > 0.005.

Tweet this
Alterity Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alterity Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alterity Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alterity Therapeutics Ltd. The current macd is 0.00024711.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alterity Therapeutics Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alterity Therapeutics Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alterity Therapeutics Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alterity Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAlterity Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alterity Therapeutics Ltd. The current adx is 12.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Alterity Therapeutics Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Alterity Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alterity Therapeutics Ltd. The current sar is 0.00745122.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Alterity Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alterity Therapeutics Ltd. The current rsi is 45.10. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Alterity Therapeutics Ltd Daily Relative Strength Index (RSI) ChartAlterity Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alterity Therapeutics Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alterity Therapeutics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alterity Therapeutics Ltd Daily Stochastic Oscillator ChartAlterity Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alterity Therapeutics Ltd. The current cci is -41.66666667.

Alterity Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartAlterity Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alterity Therapeutics Ltd. The current cmo is -23.50253598.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Alterity Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartAlterity Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alterity Therapeutics Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Alterity Therapeutics Ltd Daily Williams %R ChartAlterity Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alterity Therapeutics Ltd. The current atr is 0.00082167.

Alterity Therapeutics Ltd Daily Average True Range (ATR) ChartAlterity Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alterity Therapeutics Ltd. The current obv is 157,156,517.

Alterity Therapeutics Ltd Daily On-Balance Volume (OBV) ChartAlterity Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alterity Therapeutics Ltd. The current mfi is 51.18.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alterity Therapeutics Ltd Daily Money Flow Index (MFI) ChartAlterity Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alterity Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Alterity Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alterity Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.097
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.005
Ma 100Greater thanMa 2000.005
OpenGreater thanClose0.006
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alterity Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Alterity Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alterity Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alterity Therapeutics Ltd

I send you an email if I find something interesting about Alterity Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Alterity Therapeutics Ltd.

Receive notifications about Alterity Therapeutics Ltd in your mailbox!